#$%^&*AU2009202069B220120216.pdf#####P:OPER MJC30785725 div.doc-20M2O09 ABSTRACT 5 The present invention relates to a solid oral dosage form comprising a therapeutically effective amount of aliskiren or a pharmaceutically acceptable salt thereof, and wherein the active ingredient is present in an amount of more than 46% by weight based on the total weight of the oral dosage form. 10